Abstract
Background and aims
Bariatric surgery is the most effective treatment for morbid obesity. The classic procedure, jejunoileal bypass, has many complications including rapid progress of liver disease. The senior author (I.F.) has developed a modification of jejunoileal bypass, which we believe overcomes many of the shortcomings of the classic procedure.
Methods
Consecutive patients referring for bariatric surgery were included. A modified jejunoileal bypass in which the defunctionalized limb is eliminated by anastomosing its ends to the gall bladder and cecum was performed. Liver biopsies were taken during operation and at a mean of 16 months later. The patients were followed for 5 years.
Results
Forty-three patients were enrolled. The mean value of weight and body mass index (BMI) fell from 128 kg and 46 kg/m2 before operation to 85 kg and 31 kg/m2 at 5 years, respectively (p < 0.001). There was no significant change in the degree of liver steatosis and necroinflammation. The mean liver fibrosis score increased from 0.1 to 0.9 (p = 0.015). No sign of advanced liver disease was observed during the 5-year follow-up.
Conclusion
The modified jejunoileal bypass is very effective in inducing and maintaining weight loss for 5 years and does not lead to hepatic failure or rapid progression of liver disease.
Similar content being viewed by others
References
Malekzadeh R, Mohamadnejad M, Merat S, Pourshams A, Etemadi A. Obesity pandemic: an Iranian perspective. Archives of Iranian Medicine 2005;8:1–7.
Bahrami H, Sadatsafavi M, Pourshams A, Kamangar F, Nouraie M, Semnani S, Brennan P, Boffetta P, Malekzadeh R. Obesity and hypertension in an Iranian cohort study; Iranian women experience higher rates of obesity and hypertension than American women. BMC Public Health 2006;6:158.
Lara MD, Kothari SN, Sugerman HJ. Surgical management of obesity: a review of the evidence relating to the health benefits and risks. Treatments in Endocrinol 2005;4:55–64.
Klein S, Mittendorfer B, Eagon JC, Patterson B, Grant L, Feirt N, Seki E, Brenner D, Korenblat K, McCrea J. Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology 2006;130:1564–1572.
Mottin CC, Moretto M, Padoin AV, Kupski C, Swarowsky AM, Glock L, Duval V, da Silva JB. Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery. Obes Surg 2005;15:788–793.
Gastrointestinal surgery for severe obesity. NIH consensus development conference, March 25–27,1991. Nutrition 1996;12:397–404.
Brolin RE. Update: NIH consensus conference. Gastrointestinal surgery for severe obesity. Nutrition 1996;12:403–404.
Schneider BE, Mun EC. Surgical management of morbid obesity. Diabetes Care 2005;28:475–480.
Holzbach RT. Hepatic effects of jejunoileal bypass for morbid obesity. Am J Clin Nutr 1977;30:43–52.
Moxley RT, III, Pozefsky T, Lockwood DH. Protein nutrition and liver disease after jejunoileal bypass for morbid obesity. N Engl J Med 1974;290:921–926.
Geiss DM, Shields S, Watts JD. Reversibility of hepatic failure following jejunoileal bypass. Arch Surg 1976;111:1362–1365.
Dean P, Joshi S, Kaminski DL. Long-term outcome of reversal of small intestinal bypass operations. Am J Surg 1990;159:118–123.
Styblo T, Martin S, Kaminski DL. The effects of reversal of jejunoileal bypass operations on hepatic triglyceride content and hepatic morphology. Surgery 1984;96:632–641.
Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RN. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696–699.
Hamilton DL, Vest TK, Brown BS, Shah AN, Menguy RB, Chey WY. Liver injury with alcoholiclike hyalin after gastroplasty for morbid obesity. Gastroenterology 1983;85:722–726.
Reid AE. Nonalcoholic steatohepatitis. Gastroenterology 2001;121:710–723.
Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221–1231.
Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: Implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 1997;94:2557–2562.
Mezey E, Imbembo AL, Potter JJ, Rent KC, Lombardo R, Holt PR. Endogenous ethanol production and hepatic disease following jejunoileal bypass for morbid obesity. Am J Clin Nutr 1975;28:1277–1283.
Wigg AJ, Roberts-Thomson IC, Dymock RB, McCarthy PJ, Grose RH, Cummins AG. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001;48:206–211.
Shaffer EA. Bariatric surgery: a promising solution for nonalcoholic steatohepatitis in the very obese. J Clin Gastroenterol 2006;40:S44–S50.
Scopinaro N. Biliopancreatic diversion: mechanisms of action and long-term results. Obes Surg 2006;16:683–689.
Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg 1998;8:267–282.
Guedea ME, Arribas dA, Solanas JA, Marco CA, Bernado AJ, Rodrigo MA, Diago VA, Diez MM. Results of biliopancreatic diversion after five years. Obes Surg 2004;14:766–772.
Bouldin MJ, Ross LA, Sumrall CD, Loustalot FV, Low AK, Land KK. The effect of obesity surgery on obesity comorbidity. Am J Med Sci 2006;331:183–193.
Stratopoulos C, Papakonstantinou A, Terzis I, Spiliadi C, Dimitriades G, Komesidou V, Kitsanta P, Argyrakos T, Hadjiyannakis E. Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Obes Surg 2005;15:1154–1160.
Kral JG, Thung SN, Biron S, Hould FS, Lebel S, Marceau S, Simard S, Marceau P. Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery 2004;135:48–58.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fazel, I., Pourshams, A., Merat, S. et al. Modified Jejunoileal Bypass Surgery with Biliary Diversion for Morbid Obesity and Changes in Liver Histology During Follow-up. J Gastrointest Surg 11, 1033–1038 (2007). https://doi.org/10.1007/s11605-007-0184-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11605-007-0184-1